LYMPHOMA, NON-HODGKIN'S

Clinical trials for LYMPHOMA, NON-HODGKIN'S explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, NON-HODGKIN'S trials appear

Sign up with your email to follow new studies for LYMPHOMA, NON-HODGKIN'S, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

First patients sought for groundbreaking blood cancer drug trial

Disease control Not yet recruiting

This is the first study in people testing a new drug called LY4584180 for adults with certain blood cancers that have come back or stopped responding to previous treatments. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs tha…

Matched conditions: LYMPHOMA, NON-HODGKIN'S

Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

LYMPHOMA, NON-HODGKIN'S

Get alerted when new LYMPHOMA, NON-HODGKIN'S trials appear

First patients sought for groundbreaking blood cancer drug trial